A Conversation with the New KI Director

The Koch Institute celebrates the appointment of Matthew Vander Heiden as the fifth director of MIT's NCI-designated cancer research program. A pioneer in cancer metabolism as well as a practicing oncologist, Dr. Vander Heiden brings deep experience and keen insight to the multi-faceted work of the Koch Institute community. On Thursday, April 29 he joins MIT President Emerita Susan Hockfield in a virtual conversation about his vision for cancer research at MIT.

Featured Speakers

Susan Hockfield, PhD

MIT President Emerita and Professor of Neuroscience

Matthew Vander Heiden, MD, PhD

Koch Institute Director and Associate Professor of Biology